MPCCC has joined forces with the Victorian Comprehensive Cancer Centre (VCCC) to coordinate a response to COVID-19. A new collaborative platform will help health professionals respond [...]

Cancer patients are likely to benefit from more targeted treatments following work that has increased the number of identifiable cancer genome signatures to 97. The [...]

Cancer patients treated in Victoria will benefit from more affordable access to molecular tumour profiling, following a new collaboration between the Australian Genomic Cancer Medicine [...]

The MPCCC has reviewed and enhanced its executive team and in coming weeks will form a new advisory committee to ensure both regional and state-wide [...]

As we reach the end of 2019, we reflect on many fine achievements across our partner organisations and close the year with two sentiments in mind: gratitude and [...]

Patients at Monash Health’s cancer clinic in Berwick are the first to participate in an MPCCC-funded project piloting the real-time collection of patient-reported outcome measures [...]

Monash Health, in collaboration with the Cancer Council Victoria and the Southern Melbourne Integrated Cancer Service, held a focus group on 18 November 2019 for [...]

A next-generation sequencing instrument, the NovaSeq6000, will build genomic research capacity for MPCCC partners and increase the speed and affordability of comprehensive tumour genome profiling [...]

MPCCC is set to introduce next generation sequencing (NGS)-based tumour genomic profiling to melanoma multi-disciplinary meetings (MDM’s). The pilot program is co-ordinated by the MPCCC’s [...]

MPCCC’s pilot study of a collaborative care model for cancer-related depression is feasible and could be readily implemented statewide to benefit all Victorian cancer patients, [...]